TP53 and cancer: PTEN can inhibit PI3K-AKT pathway that can promote the nuclear localization of MDM2 and the downregulation of p53, which may reveal the mechanism of cancer chemotherapy resistance to a certain extent.447,448 Cancer produces growth and survival factors that activate PI3K through autocrine or paracrine mechanisms.